FibroGen
FGEN
$13.01
Share price
-1.89%
Change (1 day)
25.82%
Change (1 year)
Market capitalization of FibroGen (FGEN)
Market cap: $1.21 Billion
As of October 2022 FibroGen has a market cap of $1.21 Billion. This makes FibroGen the world's 4214th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of FibroGen from 2014 to 2022
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2022 | $1.21 B | -6.7% |
| 2021 | $1.30 B | -61.27% |
| 2020 | $3.37 B | -10.21% |
| 2019 | $3.75 B | -4.91% |
| 2018 | $3.95 B | 1.48% |
| 2017 | $3.89 B | 188.26% |
| 2016 | $1.35 B | -28.44% |
| 2015 | $1.88 B | 17% |
| 2014 | $1.61 B |
End of Day market cap according to different sources
On Oct 2nd, 2022 the market cap of FibroGen was reported to be:
$1.21 Billion
$1.21 Billion
$1.20 Billion
$1.21 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Illumina ILMN | $30.01 B | 2,360.80% | 🇺🇸 USA |
 Acceleron Pharma XLRN | $10.93 B | 796.35% | 🇺🇸 USA |
 Accelerate Diagnostics AXDX | $0.15 B | -87.65% | 🇺🇸 USA |